Liaison(s): Ian Collins, Claudia Berdugo-Davis, NaTasha Edwards, Emily Schirmer, Vic Vinci, William Wessel
Catalyst + Talent = Catalent. That is the mantra that has made Catalent Pharma Solutions the #1 drug development, delivery, and supply partner in the world. Catalent is based in Somerset, New Jersey with over 30+ sites and 50+ clinical depots internationally, with over 180+ products launched annually. As a contract development and manufacturing organization (CDMO) working largely with small to mid-sized companies, Catalent is dedicated to keeping pace with industry trends towards process intensification, speed, and flexibility while maintaining the same gold standard of quality and supply they have offered since 2007.
Catalent has contracted our diverse team of graduate student engineers to investigate the CDMO business model and continuous processing in order to offer innovative process intensification solutions to their unique client base. Our team has assessed the benefits and challenges of implementing continuous processing at clinical and commercial demands for small to midsize companies. We have also completed a multifaceted market survey to understand the demand in this space. The team has leveraged technical bioprocess expertise to design various implementations of continuous bioprocesses and created computational simulations modeling for each bioprocessing platform within a design space of diverse process parameters. A complete business case is being drafted in comparing the batch to continuous processes across scales over varying clinical and commercial demands.